Baseline abnormal liver function tests are more important than age in the development of isoniazid-induced hepatoxicity for patients receiving preventive therapy for latent tuberculosis infection-Reference-Cited by-同舟云学术

Baseline abnormal liver function tests are more important than age in the development of isoniazid-induced hepatoxicity for patients receiving preventive therapy for latent tuberculosis infection

Published:2016-03 Issue:3 Volume:46 Page:281-287
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Intern Med J

Author:

Gray E. L.¹,Goldberg H. F.¹

Affiliation:

1. Department of Respiratory Medicine; Prince of Wales Hospital; Sydney New South Wales Australia

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/imj.12979/fullpdf

Reference31 articles.

1. Management of latent tuberculosis infections in Australia and New Zealand: a review of current practice;Denholm;Tuber Res Treat,2010

2. Targeted tuberculin skin testing and treatment of latent tuberculosis infection;Centers for Disease Control and Prevention;Morb Mortal Wkly Rep,2000

3. How much isoniazid is needed for prevention of tuberculosis in immunocompetent adults;Comstock;Int J Tuber Lung Dis,1999

4. Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada;Hirsch-Moverman;Int J Tuber Lung Dis,2008

5. An official ATS statement: hepatotoxicity of antituberculosis therapy;American Thoracic Society;Am J Respir Crit Care Med,2006

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis, prevention and risk-management of drug-induced liver injury due to medications used to treat mycobacterium tuberculosis;Expert Opinion on Drug Safety;2024-09-04

2. Drug and Toxin-Induced Liver Injury;Atlas of Liver Pathology;2024

3. Pulmonary tuberculosis and diabetes mellitus: Epidemiology, pathogenesis and therapeutic management (Review);Medicine International;2023-12-21

4. AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury;Hepatology;2023-02-17

5. A pharmacovigilance study of terbinafine indication and liver enzyme elevation;JAAD International;2022-09